T1	PROC 1 27	Comparación de la eficacia
#1	AnnotatorNotes T1	C1707887; Efficacy Study; Research Activity
T2	DISO 44 69	dolor neuropático crónico
#2	AnnotatorNotes T2	C4544057; Chronic neuropathic pain; Finding
T3	PROC 1733 1760	presión arterial diastólica
#3	AnnotatorNotes T3	C1305849; Diastolic blood pressure measurement; Diagnostic Procedure
T4	CHEM 84 93	oxicodona
#4	AnnotatorNotes T4	C0030049; oxycodone; Organic Chemical · Pharmacologic Substance
T5	CHEM 98 107	lidocaína
#5	AnnotatorNotes T5	C0023660; lidocaine; Organic Chemical · Pharmacologic Substance
T6	CHEM 130 138	tramadol
#6	AnnotatorNotes T6	C0040610; tramadol; Organic Chemical · Pharmacologic Substance
T7	CHEM 143 152	lidocaína
#7	AnnotatorNotes T7	C0023660; lidocaine; Organic Chemical · Pharmacologic Substance
T8	PROC 177 198	Se evaluó la eficacia
#8	AnnotatorNotes T8	C1707887; Efficacy Study; Research Activity
T9	CHEM 202 211	oxicodona
#9	AnnotatorNotes T9	C0030049; oxycodone; Organic Chemical · Pharmacologic Substance
T10	CHEM 216 225	lidocaína
#10	AnnotatorNotes T10	C0023660; lidocaine; Organic Chemical · Pharmacologic Substance
T11	CHEM 245 253	tramadol
#11	AnnotatorNotes T11	C0040610; tramadol; Organic Chemical · Pharmacologic Substance
T12	CHEM 258 267	lidocaína
#12	AnnotatorNotes T12	C0023660; lidocaine; Organic Chemical · Pharmacologic Substance
T13	PROC 2005 2024	frecuencia cardíaca
#13	AnnotatorNotes T13	C2197023; examination of heart rate; Health Care Activity
T14	DISO 305 330	dolor neuropático crónico
#14	AnnotatorNotes T14	C4544057; Chronic neuropathic pain; Finding
T15	DISO 490 495	Dolor
#15	AnnotatorNotes T15	C0030193; Pain; Sign or Symptom | C0234238; Ache; Sign or Symptom
T16	ANAT 2035 2043	arterial
#16	AnnotatorNotes T16	C0003842; Arteries; Body Part, Organ, or Organ Component | C1285085; Entire artery; Body Part, Organ, or Organ Component
T17	PROC 656 667	diagnóstico
#17	AnnotatorNotes T17	C0011900; Diagnosis; Diagnostic Procedure
T18	PROC 802 825	escala visual analógica
#18	AnnotatorNotes T18	C0042815; Visual Analog Pain Scale; Diagnostic Procedure | C2959685; Assessment using visual analog scale; Health Care Activity
T19	PROC 827 830	EVA
#19	AnnotatorNotes T19	C0042815; Visual Analog Pain Scale; Diagnostic Procedure | C2959685; Assessment using visual analog scale; Health Care Activity
T20	CHEM 925 934	oxicodona
#20	AnnotatorNotes T20	C0030049; oxycodone; Organic Chemical · Pharmacologic Substance
T21	CHEM 947 956	lidocaína
#21	AnnotatorNotes T21	C0023660; lidocaine; Organic Chemical · Pharmacologic Substance
T22	PROC 970 988	perfusión continua
#22	AnnotatorNotes T22	C0444889; Continuous infusion; Therapeutic or Preventive Procedure
T23	CHEM 1017 1025	tramadol
#23	AnnotatorNotes T23	C0040610; tramadol; Organic Chemical · Pharmacologic Substance
T24	CHEM 1039 1048	lidocaína
#24	AnnotatorNotes T24	C0023660; lidocaine; Organic Chemical · Pharmacologic Substance
T25	PROC 1062 1080	perfusión continua
#25	AnnotatorNotes T25	C0444889; Continuous infusion; Therapeutic or Preventive Procedure
T26	PROC 1169 1180	diagnostica
#26	AnnotatorNotes T26	C0011900; Diagnosis; Diagnostic Procedure
T27	PROC 1182 1185	EVA
#27	AnnotatorNotes T27	C0042815; Visual Analog Pain Scale; Diagnostic Procedure | C2959685; Assessment using visual analog scale; Health Care Activity
T28	DISO 1209 1224	alodinia táctil
T29	DISO 1226 1234	alodinia
#28	AnnotatorNotes T29	C0458247; Allodynia; Finding
T30	DISO 1245 1257	hiperalgesia
#29	AnnotatorNotes T30	C0020429; Hyperalgesia; Sign or Symptom
T31	DISO 1287 1306	efectos secundarios
#30	AnnotatorNotes T31	C0041755; Adverse reaction to drug; Pathologic Function | C0559546; Adverse reactions; Pathologic Function | C0879626; Adverse effects; Pathologic Function
T32	PROC 1323 1334	tratamiento
#31	AnnotatorNotes T32	C0087111; Therapeutic procedure; Therapeutic or Preventive Procedure
T33	ANAT 1348 1364	cardiovasculares
#32	AnnotatorNotes T33	C0007226; Cardiovascular system; Body System | C3887460; Cardiovascular; Body Location or Region
T34	CHEM 1586 1595	oxicodona
#33	AnnotatorNotes T34	C0030049; oxycodone; Organic Chemical · Pharmacologic Substance
T35	CHEM 1600 1609	lidocaína
#34	AnnotatorNotes T35	C0023660; lidocaine; Organic Chemical · Pharmacologic Substance
T36	PROC 1613 1631	perfusión continua
#35	AnnotatorNotes T36	C0444889; Continuous infusion; Therapeutic or Preventive Procedure
T37	DISO 1891 1910	efectos secundarios
#36	AnnotatorNotes T37	C0041755; Adverse reaction to drug; Pathologic Function | C0559546; Adverse reactions; Pathologic Function | C0879626; Adverse effects; Pathologic Function
T38	PROC 1933 1944	tratamiento
#37	AnnotatorNotes T38	C0087111; Therapeutic procedure; Therapeutic or Preventive Procedure
T39	CHEM 2137 2146	Oxicodona
#38	AnnotatorNotes T39	C0030049; oxycodone; Organic Chemical · Pharmacologic Substance
T40	CHEM 2151 2160	lidocaína
#39	AnnotatorNotes T40	C0023660; lidocaine; Organic Chemical · Pharmacologic Substance
T41	PROC 2164 2182	perfusión continua
#40	AnnotatorNotes T41	C0444889; Continuous infusion; Therapeutic or Preventive Procedure
T42	ANAT 2220 2234	cardiovascular
#41	AnnotatorNotes T42	C0007226; Cardiovascular system; Body System | C3887460; Cardiovascular; Body Location or Region
T43	DISO 2276 2301	dolor neuropático crónico
#42	AnnotatorNotes T43	C4544057; Chronic neuropathic pain; Finding
T44	PROC 522 623	ensayo clínico controlado de tipo experimental, prospectivo, comparativo, longitudinal y aleatorizado
#43	AnnotatorNotes T44	C0206035; Controlled Clinical Trials, Randomized; Research Activity + C0678323; experimentation; Research Activity + C0033522; Prospective Studies; Research Activity + C1579762; comparative study research; Research Activity + C0023981; Longitudinal Studies; Research Activity
T45	DISO 671 715	dolor espontáneo de tipo neuropático crónico
#44	AnnotatorNotes T45	C4544057; Chronic neuropathic pain; Finding
T46	DISO 1152 1157	dolor
#45	AnnotatorNotes T46	C0030193; Pain; Sign or Symptom | C0234238; Ache; Sign or Symptom
T47	DISO 1191 1207	dolor espontáneo
#46	AnnotatorNotes T47	C1997216; Spontaneous pain; Sign or Symptom
T48	PROC 1277 1285	sedación
#47	AnnotatorNotes T48	C0344106; Sedation procedure; Therapeutic or Preventive Procedure
T49	DISO 1647 1663	dolor espontáneo
#48	AnnotatorNotes T49	C1997216; Spontaneous pain; Sign or Symptom
T50	ANAT 1741 1749	arterial
#49	AnnotatorNotes T50	C0003842; Arteries; Body Part, Organ, or Organ Component | C1285085; Entire artery; Body Part, Organ, or Organ Component
T51	PROC 1850 1858	sedación
#50	AnnotatorNotes T51	C0344106; Sedation procedure; Therapeutic or Preventive Procedure
T52	ANAT 2016 2024	cardíaca
#51	AnnotatorNotes T52	C0018787; Heart; Body Part, Organ, or Organ Component | C1281570; Entire heart; Body Part, Organ, or Organ Component
T53	PROC 2027 2053	presión arterial sistólica
#52	AnnotatorNotes T53	C1306620; Systolic blood pressure measurement; Diagnostic Procedure
T55	Duration 62 69	crónico
#53	AnnotatorNotes T55	C0205191; chronic; Temporal Concept
T56	Route 108 120	intravenosas
#54	AnnotatorNotes T56	C1522726; Intravenous Route of Drug Administration; Functional Concept
T57	Route 153 165	intravenosas
#55	AnnotatorNotes T57	C1522726; Intravenous Route of Drug Administration; Functional Concept
T58	Route 272 287	vía intravenosa
#56	AnnotatorNotes T58	C1522726; Intravenous Route of Drug Administration; Functional Concept
T60	Duration 323 330	crónico
#57	AnnotatorNotes T60	C0205191; chronic; Temporal Concept
T61	LIVB 642 651	pacientes
#58	AnnotatorNotes T61	C0030705; Patients; Patient or Disabled Group
T62	Duration 708 715	crónico
#59	AnnotatorNotes T62	C0205191; chronic; Temporal Concept
T63	Duration 770 784	al menos 1 mes
T65	Dose 936 941	10 mg
T66	Dose 958 965	3 mg/kg
T67	Route 970 979	perfusión
#60	AnnotatorNotes T67	C1621368; Intravenous Drip Route of Administration; Functional Concept
T68	LIVB 1001 1014	grupo control
#61	AnnotatorNotes T68	C0009932; Control Groups; Group
T69	Dose 1027 1033	100 mg
T70	Dose 1050 1057	3 mg/kg
T71	Route 1062 1071	perfusión
#62	AnnotatorNotes T71	C1621368; Intravenous Drip Route of Administration; Functional Concept
T72	LIVB 1562 1571	pacientes
#63	AnnotatorNotes T72	C0030705; Patients; Patient or Disabled Group
T73	Route 1613 1622	perfusión
#64	AnnotatorNotes T73	C1621368; Intravenous Drip Route of Administration; Functional Concept
T74	PHYS 1733 1749	presión arterial
#65	AnnotatorNotes T74	C0005823; Blood Pressure; Organism Function
T76	LIVB 1866 1875	pacientes
#66	AnnotatorNotes T76	C0030705; Patients; Patient or Disabled Group
T79	PHYS 2027 2043	presión arterial
#67	AnnotatorNotes T79	C0005823; Blood Pressure; Organism Function
T80	Route 2164 2173	perfusión
#68	AnnotatorNotes T80	C1621368; Intravenous Drip Route of Administration; Functional Concept
T82	Duration 2294 2301	crónico
#69	AnnotatorNotes T82	C0205191; chronic; Temporal Concept
T83	LIVB 2334 2347	grupo control
#70	AnnotatorNotes T83	C0009932; Control Groups; Group
T84	LIVB 2380 2389	pacientes
#71	AnnotatorNotes T84	C0030705; Patients; Patient or Disabled Group
T86	PHYS 1218 1224	táctil
#72	AnnotatorNotes T86	C0702221; Touch sensation; Organ or Tissue Function
T54	LIVB 906 922	grupo de estudio
#73	AnnotatorNotes T54	C2986530; Intervention Group; Population Group | C5205743; Experimental Group; Population Group
T59	CONC 841 863	criterios de exclusión
A1	Assertion T59 Negated
#74	AnnotatorNotes T59	C0680251; Exclusion Criteria; Functional Concept
T64	Neg_cue 837 840	sin
R1	Negation Arg1:T64 Arg2:T59	
T75	Neg_cue 1801 1803	No
T77	CONC 1818 1825	cambios
A2	Assertion T77 Negated
#75	AnnotatorNotes T77	C0443172; Changed status; Quantitative Concept
R2	Negation Arg1:T75 Arg2:T77	
T78	CONC 1963 1970	cambios
A3	Assertion T78 Negated
#76	AnnotatorNotes T78	C0443172; Changed status; Quantitative Concept
T81	Neg_cue 1946 1948	No
R3	Negation Arg1:T81 Arg2:T78	
T85	Observation 294 300	alivio
#77	AnnotatorNotes T85	C1998289; Pain relief by medication; Finding
T87	Observation 34 40	alivio
#78	AnnotatorNotes T87	C1998289; Pain relief by medication; Finding
R4	Has_Duration_or_Interval Arg1:T2 Arg2:T55	
R5	Combined_with Arg1:T4 Arg2:T5	
R6	Has_Route_or_Mode Arg1:T5 Arg2:T56	
R7	Has_Route_or_Mode Arg1:T4 Arg2:T56	
T88	Quantifier_or_Qualifier 70 79	agudizado
#79	AnnotatorNotes T88	C0439557; Acute phase; Temporal Concept
R8	Has_Quantifier_or_Qualifier Arg1:T2 Arg2:T88	
T89	Quantifier_or_Qualifier 716 725	agudizado
#80	AnnotatorNotes T89	C0439557; Acute phase; Temporal Concept
R9	Has_Quantifier_or_Qualifier Arg1:T45 Arg2:T89	
R10	Has_Duration_or_Interval Arg1:T45 Arg2:T62	
T90	Quantifier_or_Qualifier 331 340	agudizado
#81	AnnotatorNotes T90	C0439557; Acute phase; Temporal Concept
R11	Has_Quantifier_or_Qualifier Arg1:T14 Arg2:T90	
R12	Has_Duration_or_Interval Arg1:T14 Arg2:T60	
T91	Quantifier_or_Qualifier 2302 2311	agudizado
#82	AnnotatorNotes T91	C0439557; Acute phase; Temporal Concept
R13	Has_Quantifier_or_Qualifier Arg1:T43 Arg2:T91	
R14	Has_Duration_or_Interval Arg1:T43 Arg2:T82	
R15	Causes Arg1:T38 Arg2:T37	
R16	Experiences Arg1:T76 Arg2:T38	
R17	Experiences Arg1:T76 Arg2:T51	
R18	Location_of Arg1:T52 Arg2:T13	
R19	Location_of Arg1:T16 Arg2:T79	
R20	Location_of Arg1:T16 Arg2:T53	
R22	Causes Arg1:T4 Arg2:T87	
R23	Combined_with Arg1:T6 Arg2:T7	
R24	Has_Route_or_Mode Arg1:T7 Arg2:T57	
R25	Has_Route_or_Mode Arg1:T6 Arg2:T57	
R26	Causes Arg1:T6 Arg2:T87	
R27	Before Arg1:T2 Arg2:T87	
R28	Combined_with Arg1:T9 Arg2:T10	
R29	Combined_with Arg1:T11 Arg2:T12	
R30	Has_Route_or_Mode Arg1:T12 Arg2:T58	
R31	Has_Route_or_Mode Arg1:T11 Arg2:T58	
R32	Has_Route_or_Mode Arg1:T9 Arg2:T58	
R33	Has_Route_or_Mode Arg1:T10 Arg2:T58	
R34	Causes Arg1:T11 Arg2:T85	
R35	Causes Arg1:T9 Arg2:T85	
R36	Before Arg1:T14 Arg2:T85	
R37	Experiences Arg1:T61 Arg2:T45	
T92	Quantifier_or_Qualifier 727 744	moderado a severo
#83	AnnotatorNotes T92	C1299393; Moderate to severe; Qualitative Concept
R38	Has_Quantifier_or_Qualifier Arg1:T45 Arg2:T92	
T93	CONC 788 797	evolución
#84	AnnotatorNotes T93	C0449259; Clinical course; Temporal Concept
R39	Has_Duration_or_Interval Arg1:T93 Arg2:T63	
R41	Experiences Arg1:T61 Arg2:T18	
T94	Result_or_Value 832 835	> 4
R42	Has_Result_or_Value Arg1:T19 Arg2:T94	
R43	Has_Result_or_Value Arg1:T18 Arg2:T94	
R44	Experiences Arg1:T61 Arg2:T19	
R46	Experiences Arg1:T54 Arg2:T20	
R48	Combined_with Arg1:T20 Arg2:T21	
R49	Has_Dose_or_Strength Arg1:T20 Arg2:T65	
R50	Has_Dose_or_Strength Arg1:T21 Arg2:T66	
R51	Has_Route_or_Mode Arg1:T21 Arg2:T67	
R52	Has_Route_or_Mode Arg1:T20 Arg2:T67	
R53	Used_for Arg1:T20 Arg2:T22	
R47	Experiences Arg1:T68 Arg2:T23	
R54	Combined_with Arg1:T23 Arg2:T24	
R55	Has_Dose_or_Strength Arg1:T23 Arg2:T69	
R56	Has_Dose_or_Strength Arg1:T24 Arg2:T70	
R57	Used_for Arg1:T23 Arg2:T25	
R58	Has_Route_or_Mode Arg1:T23 Arg2:T71	
R59	Has_Route_or_Mode Arg1:T24 Arg2:T71	
R60	Experiences Arg1:T68 Arg2:T45	
R61	Experiences Arg1:T54 Arg2:T45	
R62	Experiences Arg1:T54 Arg2:T18	
R63	Experiences Arg1:T68 Arg2:T18	
T95	CONC 1108 1130	variables demográficas
#85	AnnotatorNotes T95	C4684639; Demographic Data; Intellectual Product
T96	CONC 1159 1180	categoría diagnostica
T97	Quantifier_or_Qualifier 1235 1242	al frío
R67	Has_Quantifier_or_Qualifier Arg1:T29 Arg2:T97	
#86	AnnotatorNotes T96	C1550395; Major Diagnostic Category; Classification (?)
T98	Observation 1268 1285	grado de sedación
#87	AnnotatorNotes T98	C5424666; Sedation total score; Finding (?)
T99	CONC 1337 1364	parámetros cardiovasculares
T100	Observation 1308 1334	satisfacción a tratamiento
#88	AnnotatorNotes T100	C3476649; Treatment satisfaction; Finding
R68	Overlap Arg1:T100 Arg2:T32	
T101	CONC 1422 1434	prueba de χ2
#89	AnnotatorNotes T101	C0008041; Chi-Square Test; Intellectual Product
T102	CONC 1437 1454	U de Mann-Whitney
#90	AnnotatorNotes T102	C0242927; Mann-Whitney U Test; Quantitative Concept
T103	CONC 1521 1528	cambios
#91	AnnotatorNotes T103	C0443172; Changed status; Quantitative Concept
R69	Experiences Arg1:T72 Arg2:T34	
R70	Combined_with Arg1:T34 Arg2:T35	
R71	Has_Route_or_Mode Arg1:T34 Arg2:T73	
R72	Has_Route_or_Mode Arg1:T35 Arg2:T73	
R73	Used_for Arg1:T34 Arg2:T36	
R74	Experiences Arg1:T72 Arg2:T49	
T104	CONC 1671 1697	momentos 7 y 8 del estudio
T105	CONC 1778 1787	momento 8
R75	Overlap Arg1:T49 Arg2:T104	
R76	Location_of Arg1:T50 Arg2:T74	
R77	Location_of Arg1:T50 Arg2:T3	
T106	CONC 1708 1715	cambios
#92	AnnotatorNotes T106	C0443172; Changed status; Quantitative Concept
R79	Overlap Arg1:T103 Arg2:T104	
R81	Overlap Arg1:T106 Arg2:T105	
R83	Overlap Arg1:T3 Arg2:T105	
T107	Observation 1913 1944	satisfacción con el tratamiento
#93	AnnotatorNotes T107	C3476649; Treatment satisfaction; Finding
R84	Overlap Arg1:T107 Arg2:T38	
R85	Experiences Arg1:T76 Arg2:T37	
R86	Experiences Arg1:T76 Arg2:T107	
R87	Combined_with Arg1:T39 Arg2:T40	
R88	Has_Route_or_Mode Arg1:T39 Arg2:T80	
R89	Has_Route_or_Mode Arg1:T40 Arg2:T80	
R90	Used_for Arg1:T39 Arg2:T41	
R91	Used_for Arg1:T40 Arg2:T41	
T108	Observation 2208 2234	estabilidad cardiovascular
T109	Observation 2239 2258	efectos analgésicos
#94	AnnotatorNotes T109	C0948482; Analgesic effect; Finding
R93	Causes Arg1:T39 Arg2:T109	
T110	Observation 2265 2271	alivio
#95	AnnotatorNotes T110	C1998289; Pain relief by medication; Finding
R94	Causes Arg1:T39 Arg2:T110	
R95	Experiences Arg1:T83 Arg2:T43	
R96	Experiences Arg1:T83 Arg2:T110	
R97	Experiences Arg1:T83 Arg2:T109	
R98	Experiences Arg1:T83 Arg2:T108	
R100	Before Arg1:T43 Arg2:T110	
R101	Before Arg1:T43 Arg2:T109	
R102	Experiences Arg1:T61 Arg2:T15	
R103	Experiences Arg1:T54 Arg2:T15	
R104	Experiences Arg1:T68 Arg2:T15	
T111	Quantifier_or_Qualifier 1529 1543	significativos
#96	AnnotatorNotes T111	C0237881; Statistical Significance; Quantitative Concept
R40	Has_Quantifier_or_Qualifier Arg1:T103 Arg2:T111	
T112	Quantifier_or_Qualifier 1826 1834	notables
A4	Assertion T112 Negated
#97	AnnotatorNotes T112	C4288581; Notable; Qualitative Concept
R45	Has_Quantifier_or_Qualifier Arg1:T77 Arg2:T112	
R64	Negation Arg1:T75 Arg2:T112	
T113	Quantifier_or_Qualifier 1971 1984	considerables
R65	Has_Quantifier_or_Qualifier Arg1:T78 Arg2:T113	
A5	Assertion T113 Negated
R66	Negation Arg1:T81 Arg2:T113	
#98	AnnotatorNotes T113	C0750502; Significant; Idea or Concept
#99	AnnotatorNotes T28	C0751213; Tactile Allodynia; Sign or Symptom
A6	Experiencer T61 Patient
A7	Experiencer T54 Patient
A8	Experiencer T68 Patient
A9	Experiencer T72 Patient
A10	Experiencer T76 Patient
A11	Experiencer T83 Patient
A12	Experiencer T84 Patient
